<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OURD</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-6-350</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20153.94</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Melanocytes and melanogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zonunsanga</surname>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
</contrib-group>
<aff id="aff1"><italic>Department of Skin and VD, RNT Medical College, Udaipur, Rajasthan-313001, India</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Zonunsanga, E-mail: <email xlink:href="jrkos04@gmail.com">jrkos04@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2015</year>
</pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>350</fpage>
<lpage>355</lpage>
<history>
<date date-type="received"><day>25</day><month>10</month><year>2014</year></date>
<date date-type="accepted"><day>26</day><month>02</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Pigmentation is heritable and is regulated by genetic, environmental and endocrine factors. During embryogenesis, specific cells (melanoblasts) migrate from the neural crest into the basal epithelium of the epidermis, hair bulbs of the skin and specific areas of the eye, ear and brain. There are 3 types, viz. eumelanosome, pheomelanin, neuromelanin. They have special staining methods: antigens as well as antibodies.</p>
</abstract>
<kwd-group>
<kwd>Eumelanosome</kwd>
<kwd>pheomelanin</kwd>
<kwd>neuromelanin</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Pigmentation is heritable and is regulated by genetic, environmental and endocrine factors [<xref ref-type="bibr" rid="ref1">1</xref>]. Skin colour results from [<xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref3">3</xref>]:</p>
<p>
<list list-type="order">
<list-item>
<p>Concentration and admixture of the types of melanins in melanocyte (most important),</p>
</list-item>
<list-item>
<p>carotenoid pigments,</p>
</list-item>
<list-item>
<p>the number of blood vessels in the cutis, the colour of blood in them.</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec1-2">
<title>EMBRYOLOGY</title>
<p>During embryogenesis, specific cells (melanoblasts) migrate from the neural crest into the basal epithelium of the epidermis, hair bulbs of the skin and specific areas of the eye, ear and brain [<xref ref-type="bibr" rid="ref2">2</xref>].</p>
<p>Slac2-a simultaneously interacts with Rab27A on the melanosome and with an actin-based motor myosin Va, the resultant tripartite protein complex (Rab27A-Slac2-a-myosin Va) mediates actin-based melanosome transport. After actin-dependent melanosome transport, the second Rab27A effector Slp2-a promotes the anchoring of melanosomes to the plasma membrane of melanocytes through direct interaction of the C2A domain with phosphatidylserine. Melanosomes are attached to a framework of microtubules and are transported up the dendrites on ladders of actin. The little &#x201C;feet&#x201D; that walk up the actin fibers are called myosin 5. Melanin is transferred through dendritic processes from melanocytes to basal keratinocytes, where it is first stored and later degraded. The greater number of melanin is present in Basal keratinocytes than in the melanocytes and often basal cells at the tips of Rete ridges are preferentially more melanized. 10&#x0025; of cells in basal layer are melanocytes. Each melanocyte supplies 36 keratinocytes with melanin, forming Epidermal-Melanin unit [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref4">4</xref>].</p>
</sec>
<sec id="sec1-3">
<title>ANATOMY</title>
<p>They are located in the Basal layer of epidermis, Hair bulb and Outer root sheath of hair follicles [<xref ref-type="bibr" rid="ref2">2</xref>-<xref ref-type="bibr" rid="ref7">7</xref>].</p>
<sec id="sec2-1">
<title>Melanocytes in epidermis</title>
<p>Epidermal have round to oval, dark stained nuclei, smaller than those of basal keratinocytes. A clear halo of surrounding cytoplasm.</p>
</sec>
<sec id="sec2-2">
<title>Melanocytes in hair</title>
<p>Melanocytes are diffentiated into</p>
<p>
<list list-type="order">
<list-item>
<p>Differentiated melanocytes, located in the hair matrix region</p>
</list-item>
<list-item>
<p>Melanocyte stem cells, located at the lower portion of hair follicle.</p>
</list-item>
</list>
</p>
<sec id="sec3-1">
<title>Differentiated melanocytes</title>
<p>They express</p>
<p>
<list list-type="order">
<list-item>
<p>Sox 10 (Sry-related HMG box/sex determining region box 10),</p>
</list-item>
<list-item>
<p>kit,</p>
</list-item>
<list-item>
<p>mitf (micropthalmia associated transcription factors),</p>
</list-item>
<list-item>
<p>Pax 3 (paired bx 3),</p>
</list-item>
<list-item>
<p>Dct (Dopachrome tautomerase)</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec3-2">
<title>Melanocyte stem cells</title>
<p>They express only Pax 3 and Dct.</p>
</sec>
</sec>
<sec id="sec2-3">
<title>Ear</title>
<p>Melanins are found in Striae vascularis of Inner ear.</p>
</sec>
<sec id="sec2-4">
<title>Eye</title>
<p>Melanocytes are also present in the Iris stroma in the front of Iris, Iris pigment epithelium on the back of Iris, Retinal pigment epithelium.</p>
</sec>
<sec id="sec2-5">
<title>Adrenal glands</title>
<p>They are also seen in Medula and Zona reticularis.</p>
</sec>
<sec id="sec2-6">
<title>Others</title>
<p>Melanin is also found in heart, liver, muscles and intestine.</p>
</sec>
</sec>
<sec id="sec1-4">
<title>TYPES OF MELANIN [<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref7">7</xref>]</title>
<p>
<list list-type="order">
<list-item>
<p>Eumelanin (dark brown)</p>
</list-item>
<list-item>
<p>Pheomelanin (pale red or yellow)</p>
</list-item>
<list-item>
<p>Neuromelanin (produced in dopaminergic neurons of the human substantia nigra).</p>
</list-item>
</list>
</p>
<sec id="sec2-7">
<title>Phaeomelonosomes</title>
<p>
<list list-type="bullet">
<list-item>
<p>They spherical in shape</p>
</list-item>
<list-item>
<p>they lack TRP1, TRP2 and p-protein (TRP = tyrosine related proteins)</p>
</list-item>
<list-item>
<p>they have 1/3rd the level of tyrosinase as eumelanosomes.</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-8">
<title>Eumelanosomes</title>
<p>
<list list-type="bullet">
<list-item>
<p>They are oval-shaped melanosomes,</p>
</list-item>
<list-item>
<p>they have TRP1, TRP2, p-protein,</p>
</list-item>
<list-item>
<p>they have 3 times the tyrosinase as compared to phaeomelanosomes.</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-9">
<title>Neuromelanin</title>
<sec id="sec3-3">
<title>Sites</title>
<p>
<list list-type="order">
<list-item>
<p>dopaminergic neurons of Substantia nigra,</p>
</list-item>
<list-item>
<p>locus ceruleus,</p>
</list-item>
<list-item>
<p>dorsal motor nuclei of vagus nerve,</p>
</list-item>
<list-item>
<p>median raphe nucleus of Pons.</p>
</list-item>
</list>
</p>
<p>They are located in the lysosomes and are made from oxy-radical metabolites of mono-amines neurotransmitters such as Dopamine and Norepinephrine.</p>
</sec>
</sec>
</sec>
<sec id="sec1-5">
<title>LABORATORY METHODS FOR STAINING OF MELANIN</title>
<sec id="sec2-10">
<title>1. Fontano-masson method</title>
<p>Melanin granules reduce ammoniacal silver nitrate to metallic silver [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p>
</sec>
<sec id="sec2-11">
<title>2. Schmorl&#x2019;s method</title>
<p>Melanin has ability to reduce Ferricyanide to Ferrocyanide which in presence of Ferrous ion forms Prussian blue [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p>
</sec>
<sec id="sec2-12">
<title>3. Dopa-oxidase method [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]</title>
<p>This is the Most specific test, based on action of Dopa-oxidase upon Dopa.</p>
</sec>
<sec id="sec2-13">
<title>4. Bleaching technique</title>
<p>Using strong oxidising agents like KMnO4 or Hydrogen peroxide [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p>
</sec>
<sec id="sec2-14">
<title>5. Formaldehyde-induced fluorescence</title>
<p>Formalin fixation imparts a strong yellow fluorescence to unstained tissues with biogenic amines [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p>
</sec>
<sec id="sec2-15">
<title>6. PAS (Periodic acid schiff)</title>
<p>Pseudomelanin (melanosis coli) is PAS +ve while true melanin is PAS &#x2013;ve [<xref ref-type="bibr" rid="ref6">6</xref>-<xref ref-type="bibr" rid="ref14">14</xref>].</p>
</sec>
</sec>
<sec id="sec1-6">
<title>ANTIGENS AND THEIR RESPECTIVE ANTIBODIES</title>
<p>Antigens are [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref13">13</xref>]:</p>
<p>
<list list-type="alpha-lower">
<list-item>
<p>S-100 proteins</p>
</list-item>
<list-item>
<p>gp 100</p>
</list-item>
<list-item>
<p>Melan-A/MART-1</p>
</list-item>
<list-item>
<p>Tyrosinase</p>
</list-item>
<list-item>
<p>PNL 2 Antigen</p>
</list-item>
<list-item>
<p>MITF</p>
</list-item>
</list>
</p>
<p>Antibodies are [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref13">13</xref>]:</p>
<p>
<list list-type="alpha-lower">
<list-item>
<p>Anti-S-100</p>
</list-item>
<list-item>
<p>HMB 45</p>
</list-item>
<list-item>
<p>A 103/M2-7C10</p>
</list-item>
<list-item>
<p>T 311</p>
</list-item>
<list-item>
<p>PNL 2 Antibodies</p>
</list-item>
<list-item>
<p>D 5</p>
</list-item>
</list>
</p>
<sec id="sec2-16">
<title>Melanogenesis</title>
<p>TYR Gene (located in the long arm of chromosome 11 i.e chr 11 q 14 - q 21) is involved in melanogenesis [13-17].</p>
</sec>
<sec id="sec2-17">
<title>Genes involved in development of melanoblast</title>
<p>The genes/transcription factors involved in melanogenesis are Pax3, Sox10, Mitf, Edn3(endothelin 3), Ednrb (endothelin receptor B), Kit (c-Kit tyrosine kinase receptor), Kitl (Kit ligand/asSCF/steel factor) and Snai2 (also called as Slug) [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref17">17</xref>].</p>
</sec>
<sec id="sec2-18">
<title>Sites of melanogenesis</title>
<p>Melanosomes are synthesised in [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref18">18</xref>]:</p>
<p>
<list list-type="order">
<list-item>
<p>mammalian skin melanocytes,</p>
</list-item>
<list-item>
<p>choroidal melanocytes,</p>
</list-item>
<list-item>
<p>retinal pigment epithelial (RPE) cells in the eye.</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-19">
<title>Steps of melanin synthesis</title>
<sec id="sec3-4">
<title>The survival and migration of neural crest-derived cells [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]</title>
<p>It is dependent on interactions between specific receptors on the cell surface and their extracellular ligands. For example, FGF, steel factor, formerly known as mast cell growth factor, KIT ligand or stem cell factor (SCF), binds the KIT receptor on melanocytes and melanoblasts. Mutations in the KIT gene decrease the ability of the KIT receptor to be activated by the steel factor.</p>
</sec>
<sec id="sec3-5">
<title>Differentiation of melanoblasts into melanocytes [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]</title>
<p>When melanoblasts reached epidermal-dermal junction, it is differentiated into melanocytes at around sixth month of fetal life.</p>
</sec>
<sec id="sec3-6">
<title>Survival and proliferation of melanocytes [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]</title>
<p>Melanocytes have been identified within fetal epidermis as early as 50 days of gestation. Dermal melanocytes decrease in number during gestation and virtually disappear by birth. Epidermal melanocytes established at the epidermal-dermal junction continue to proliferate and start to produce melanin.</p>
</sec>
<sec id="sec3-7">
<title>Formation of melanosomes and production of melanins [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]</title>
<p>Melanocytes start producing melanosomes, highly organized elliptic membrane-bound organelles in which melanin synthesis takes place.</p>
</sec>
</sec>
</sec>
<sec id="sec1-7">
<title>BIOCHEMICAL EVENTS</title>
<p>The Tyrosine, under the influence of Tyrosinase and CU<sup>2+</sup> forms DOPA and then Dopaquinone. This Dopaquinone with the help of Cystathione or Cysteine, forms Cysteine-L-Dopa which further forms pheomelanin. When Cysteine is depleted, the Dopaquinone forms Leucodopachrome which ultimately forms eumelanin. The ratio of these two types of Melanin determines visible pigmentation. The variation in skin color among various races is determined mainly by the number, melanin content and distribution of melanosomes produced and transferred by each melanocyte to a cluster of keratinocytes surrounding it [<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref21">21</xref>].</p>
</sec>
<sec id="sec1-8">
<title>STAGES OF MELANOSOMES</title>
<sec id="sec2-20">
<title>Stage 1</title>
<p>Melanosomes are spherical endosomal vacuoles lacking tyrosinase (TYR) activity (the main enzyme involved in melanogenesis) and have no internal structural components. No melanin is present yet. They contain the melanosomal protein Pmel17, which is sorted into intraluminal vesicles (ILVs) within the organelle. A partial clathrin coat is seen which is involved in sorting proteins into ILVs of vacuolar endosomes. The presence of Pmel17 gives rise to the structurally important intraluminal fibrils that characterise stage II melanosomes [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref20">20</xref>].</p>
</sec>
<sec id="sec2-21">
<title>Stage 2</title>
<p>Melanosomes are ellipsoidal, around 0.5 micro-mm diameter. At this point, the presence and correct processing of Pmel17, an important melanosomal structural protein, determine the transformation of stage I melanosomes to elongated, fibrillar organelles known as stage II melanosomes. They contain MELANOSOMAL enzymes tyrosinase TYRP1. They exhibit minimal deposition of melanin. Melanin is deposited within cross-linked longitudinal filaments. Enzymes activity is localised in surrounding membrane. Tyrosinase and TYRP1 are traficking to melanosomes from early endosomes. They are present in tubular endosomal domain. Tyrosinase- and TYRP1-positive endosomal membranes have buds that are coated with the adaptor proteins AP1 or AP3, which play roles in sorting tyrosinase and TYRP1 to melanosomes [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref20">20</xref>].</p>
<p>BLOC1 and BLOC2 (protein complexes) plays important role in the regulation of endosome-to-melanosome transport.</p>
<p>
<list list-type="alpha-lower">
<list-item>
<p>BLOC1 &#x2013;They are located in the tubular regions on early endosomes and control the exit of cargo from early endosomes.</p>
</list-item>
<list-item>
<p>BLOC2 &#x2013; They regulate subsequent step i.e. the direction of cargo to maturing melanosomes.</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-22">
<title>Stage 3</title>
<p>Melanosomes are ellipsoidal. Melanin deposition increases by enzymatic activity and non-enzymatic polymerization. The pigment is uniformly deposited on the internal fibrils [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref20">20</xref>].</p>
</sec>
<sec id="sec2-23">
<title>Stage 4</title>
<p>Melanosomes are ellipsoidal. Melanosome is fully developed and is filled with electron-opaque organelles. Melanin production is through polymerization.</p>
<p>Key protein involved in melanosome assembly is NCKX5, encoded by the gene SLC4A5 [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref20">20</xref>].</p>
</sec>
</sec>
<sec id="sec1-9">
<title>FACTORS INFLUENCING MELANOGENESIS</title>
<sec id="sec2-24">
<title>1. Genetics and endogenous factors</title>
<p>Migration, proliferation, differentiation and survival of melanocytes is influenced by tyrosine kinase receptor KIT and its ligand stem cell factors [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref16">16</xref>].</p>
<p>Microphthalmia transcription factor (MITF) is a nuclear protein involved in:</p>
<p>
<list list-type="order">
<list-item>
<p>embryonic development of melanocytes,</p>
</list-item>
<list-item>
<p>regulation of transcription of genes involved in melanin synthesis e.g &#x2018;mi&#x2019; gene located at chromosome 3p</p>
</list-item>
</list>
</p>
<p>The two Rab27A effectors are Slac2-a (also called melanophilin) and Slp2-a; they are abundantly expressed on melanosomes and sequentially regulate melanosome transport in melanocytes. TGF-beta suppress melanogenesis by inhibiting activation of Pax3. P 53 promotes melanogenesis by suppressing TGF- beta, upregulation of alpha-MSH and KITL. E-cadherin (mediating cell-to-cell interaction) also regulates melanocytes. Dermal fibroblast is also involed in regulation of melanocytes. Notch signalling in melanocytes, an essential cell-to-cell interaction mechanism, regulates processes such as cell proliferation, cell fate decision, differentiation or stem cell maintenance [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref16">16</xref>].</p>
</sec>
<sec id="sec2-25">
<title>2. Environmental or exogenous factors</title>
<sec id="sec3-8">
<title>(A) UV Rays</title>
<p>UVA Cause immediate dark pigmentation within minutes and persists for several hours. Followed by persistent pigment darkening, which occurs within several hours and lasts for several days. UV exposure leads to increase expression of MITF (master transcriptional regulator of pigmentation) and its downstream melanogenic proteins, including Pmel 17, MART-1, TYR, TRP-1, Dct. Thereby, leading to increase in melanin content. It also increases levels of PAR 2 (Protease activated receptor) in keratinocytes which increases uptake and distribution of melanosomes by keratinocytes in the epidermis. It also increases Alpha-MSH, endothelin and ACTH which upregulate MC-1R, thereby enhancing melanocytes response to melanocortins. It also incre ases IL-1 secretion by keratinocytes, stimulating secretion of ACTH, Alpha-MSH, SCF, NGF Endothelin-1 and hFGF by keratinocytes. UV-R also causes peroxidation of lipids in cellular membranes, leading to generation of ROS, which may stimulate melanocytes to produce excess melanin [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref17">17</xref>].</p>
</sec>
<sec id="sec3-9">
<title>(B) Retinoic acid</title>
<p>It upregulates differentiation and proliferation of melanocytes through melanocortins receptors.</p>
</sec>
<sec id="sec3-10">
<title>(C) Other exogenous factors</title>
<p>
<list list-type="bullet">
<list-item>
<p>vitamin D metabolites - retinoids</p>
</list-item>
<list-item>
<p>forskolin (extract from Indian coleus plant)</p>
</list-item>
<list-item>
<p>cholera toxin</p>
</list-item>
<list-item>
<p>isobutyl-methyl-xanthines</p>
</list-item>
<list-item>
<p>di-acylglycerol and its analogues</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-26">
<title>3. Endocrine factors</title>
<p>The endocrinal products and substances responsible for melanogenesis are CRH (Corticotropin-releasing hormones), UROCORTINS (CRH-like neuro-peptide), POMC (Pro-opio-melanocortin), ACTH, alpha-MSH And beta-ENDORPHIN [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref16">16</xref>].</p>
</sec>
</sec>
<sec id="sec2-27">
<title>Mechanism of action of melanocytes</title>
<p>Melanocyte acts on Melanocyte-receptors thereby activating signaling pathways [<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref11">11</xref>-<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref19">19</xref>-<xref ref-type="bibr" rid="ref21">21</xref>].</p>
<p>
<list list-type="order">
<list-item>
<p>Melanocyte-receptors are:</p>
<p>
<list list-type="bullet">
<list-item>
<p>MC1R,</p>
</list-item>
<list-item>
<p>Melatonin receptor,</p>
</list-item>
<list-item>
<p>G-protein-coupled receptors &#x2013; Frizzled 5</p>
</list-item>
<list-item>
<p>Receptor Tyrosine kinase- c-Kit,</p>
</list-item>
<list-item>
<p>Hepatocyte Growth factor (HGF).</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Signalling pathways involved in actions of melanocytes</p>
<p>
<list list-type="bullet">
<list-item>
<p>RAS/RAF/MEK/ERK pathway,</p>
</list-item>
<list-item>
<p>PI3K/AKT pathway,</p>
</list-item>
<list-item>
<p>Notch signalling pathway.</p>
</list-item>
</list>
</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-28">
<title>Role of melanocytes</title>
<p>Melanocytes or melanin [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref12">12</xref>-<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref>].</p>
<p>
<list list-type="bullet">
<list-item>
<p>Gives skin colour,</p>
</list-item>
<list-item>
<p>Protects skin from UV-induced skin damaged and skin cancer,</p>
</list-item>
<list-item>
<p>Development of striae vascularis of cochlea and production of Endocochlear potential thereby helping hearing function,</p>
</list-item>
<list-item>
<p>Absorb toxic substances in the inner ear,</p>
</list-item>
<list-item>
<p>Maintain proper hair colour,</p>
</list-item>
<list-item>
<p>Role in eye color,</p>
</list-item>
<list-item>
<p>In CNS, different stressors, like chemicals, oxidative damage and high temperature are also suppressed by melanin,</p>
</list-item>
<list-item>
<p>Melanocortins have effects on appetite and sexual activities.</p>
</list-item>
</list>
</p>
</sec>
<sec id="sec2-29">
<title>Deleterious effects</title>
<p>In vitro studies, melanin reacts with DNA and is known to act as photosensitiser. In contrast to eumelanin, pheomelanin is prone to photodegradation and contribute to damaging effects of UVR because it can generate Hydrogen peroxide and superoxide anions and may cause mutations in melanocytes. Pheomelanin is associated with higher rates of apoptosis after UVR. Pheomelanin increases release of Histamine, thereby contributing to sun-induced erythema and oedema. Pheomelanin is UVA sensitiser that cause cell death [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref12">12</xref>-<xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref>].</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nichols</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Reams</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>The occurrence and morphogenesis of melanocytes in the connective tissues of the PET/MCV mouse strain</article-title>
<source>J Embryol Exp Morphol</source>
<year>1960</year>
<volume>8</volume>
<fpage>24</fpage>
<lpage>32</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quevedo</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Fleischmann</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Developmental biology of mammalian melanocytes</article-title>
<source>J Invest Dermatol</source>
<year>1980</year>
<volume>75</volume>
<fpage>116</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Theriault</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>LS</given-names>
</name>
</person-group>
<article-title>Ultrastructure of developing melanosomes in C57 black and pallid mice</article-title>
<source>Dev Biol</source>
<year>1970</year>
<volume>23</volume>
<fpage>261</fpage>
<lpage>75</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holbrook</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Underwood</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Gown</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kimball</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45</article-title>
<source>Anat Embryol (Berl)</source>
<year>1989</year>
<volume>180</volume>
<fpage>443</fpage>
<lpage>55</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rom&#233;ro-Graillet</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Aberdam</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Biagoli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Massabni</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ortonne</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Ballotti</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes</article-title>
<source>J Biol Chem</source>
<year>1996</year>
<volume>271</volume>
<fpage>28052</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Melanocytes: a window into the nervous system</article-title>
<source>J Invest Dermatol</source>
<year>2012</year>
<volume>132</volume>
<fpage>835</fpage>
<lpage>45</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Malek</surname>
<given-names>ZA</given-names>
</name>
<name>
<surname>Kadekaro</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Kavanagh</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Todorovic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koikov</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>McNulty</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>
<article-title>Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity</article-title>
<source>FASEB J</source>
<year>2006</year>
<volume>20</volume>
<fpage>1561</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christiansen</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Coles</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>DG</given-names>
</name>
</person-group>
<article-title>Molecular control of neural crest formation, migration and differentiation</article-title>
<source>Curr Opin Cell Biol</source>
<year>2000</year>
<volume>12</volume>
<fpage>719</fpage>
<lpage>24</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hachiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ohuchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takema</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Imokawa</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet-B-induced pigmentation</article-title>
<source>J Invest Dermatol</source>
<year>2001</year>
<volume>116</volume>
<fpage>578</fpage>
<lpage>86</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Halaban</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hebert</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Biology of Melanocytes</article-title>
<source>Fitzpatrick&#x2019;s Dermatology in General Medicine</source>
<publisher-loc>New York</publisher-loc>
<publisher-name>McGraw Hill</publisher-name>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halaban</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Langdon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Birchall</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Cuono</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes</article-title>
<source>J Cell Biol</source>
<year>1988</year>
<volume>107</volume>
<fpage>1611</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirobe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Osawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Hepatocyte growth factor controls the proliferation of cultured epidermal melanoblasts and melanocytes from newborn mice</article-title>
<source>Pigment Cell Res</source>
<year>2004</year>
<volume>17</volume>
<fpage>51</fpage>
<lpage>61</lpage>
</nlm-citation>
</ref>
<ref id="ref13">
<label>13</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kos</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Aronzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takayama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Maina</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ponzetto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Merlino</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development</article-title>
<source>Pigment Cell Res</source>
<year>1999</year>
<volume>12</volume>
<fpage>13</fpage>
<lpage>21</lpage>
</nlm-citation>
</ref>
<ref id="ref14">
<label>14</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsui</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>DeLeo</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>Ultraviolet radiation B induces differentiation and protein kinase C in normal human epidermal keratinocytes</article-title>
<source>Photodermatol Photoimmunol Photomed</source>
<year>1996</year>
<volume>12</volume>
<fpage>103</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref15">
<label>15</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Russakovsky</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gilchrest</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>The beta isoform of protein kinase C stimulates human melanogenesis by activating tyrosinase in pigment cells</article-title>
<source>J Biol Chem</source>
<year>1993</year>
<volume>268</volume>
<fpage>11742</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref16">
<label>16</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Widlund</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival</article-title>
<source>Oncogene</source>
<year>2003</year>
<volume>22</volume>
<fpage>3035</fpage>
<lpage>41</lpage>
</nlm-citation>
</ref>
<ref id="ref17">
<label>17</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Melanogenesis: a photoprotective response to DNA damage&#x003F;</article-title>
<source>Mutat Res</source>
<year>2005</year>
<volume>571</volume>
<fpage>121</fpage>
<lpage>32</lpage>
</nlm-citation>
</ref>
<ref id="ref18">
<label>18</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pernick</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Stains. Melanin</article-title>
<source>PathologyOutlines.com</source>
<year>2013</year>
<month>September</month>
<day>29</day>
<access-date>last major update June 2005</access-date>
</nlm-citation>
</ref>
<ref id="ref19">
<label>19</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillbro</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches</article-title>
<source>Int J Cosmet Sci</source>
<year>2011</year>
<volume>33</volume>
<fpage>210</fpage>
<lpage>21</lpage>
</nlm-citation>
</ref>
<ref id="ref20">
<label>20</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Huh</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>Biology of melanogenesis and the search for hypopigmenting agents</article-title>
<source>Dermatologica Sinica</source>
<year>2010</year>
<volume>28</volume>
<fpage>53</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref21">
<label>21</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Rosmarinic acid induces melanogenesis through protein kinase A activation signaling</article-title>
<source>Biochem Pharmacol</source>
<year>2007</year>
<volume>74</volume>
<fpage>960</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref22">
<label>22</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>DW</given-names>
</name>
<etal/>
</person-group>
<article-title>IL-4 inhibits the melanogenesis of normal human melanocytes through the JAK2-STAT6 signaling pathway</article-title>
<source>J Invest Dermatol</source>
<year>2013</year>
<volume>133</volume>
<fpage>528</fpage>
<lpage>36</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil,</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
